市场调查报告书
商品编码
1619012
高价值植物化合物的全球市场:原料·类型·各用途的预测 (~2032年)Global High Value Plant Compound Market Research Report Information by Source, Type, Application, Forecast Till 2032 |
预计全球高价值植物化合物市场规模将从 2023 年的 165.367 亿美元增长到 2032 年的 447.247 亿美元,预测期内复合年增长率为 11.69%。
对植物性补充剂和营养补充剂的需求是由全球健康和保健趋势所推动的。促进整体健康和解决健康问题的营养保健品是使用优质植物化合物製成的。药品、营养品、化妆品、食品和饮料等各行业对天然和有机产品的需求是全球高价值植物化合物市场的主要推动因素。由于消费者对这些化合物的健康益处的认识不断提高,以及对天然产品胜过合成产品的日益偏好,因此该市场不断增长。然而,市场面临课题,包括提取过程的高成本、监管障碍以及对植物材料可持续采购的担忧。由于提取技术的技术进步以及对研发活动的关注,预计市场进入者将获得利润丰厚的机会。
区域展望
2022年北美地区规模最大,市场规模达43亿美元。预计 2022 年至 2032 年将以 11.21% 的复合年增长率显着成长。人们对自然疗法、营养补充品和保健产品的兴趣日益浓厚,是推动北美高价值植物化合物市场扩张的主要因素。
预计 2022 年欧洲的规模将达到 34 亿美元,并在预测期内以 10.74% 的复合年增长率持续增长。市场扩张归因于欧洲消费者对高价值植物化合物的采用,特别是在化妆品和营养补充剂方面。
到 2022 年,亚太地区的市场规模将达到 67 亿美元,预计在预测期内复合年增长率为 12.02%。该地区强劲的复合年增长率归因于草药和阿育吠陀疗法在製药和食品行业的广泛采用,以及这些疗法在印度和中国等国家的日益普及。
本报告提供全球高价值植物化合物的市场调查,彙整市场定义和概要,市场成长的各种影响因素分析,市场规模的转变·预测,各种区分·地区/各主要国家的明细,竞争环境,主要企业简介等资讯。
Global High Value Plant Compound Market Research Report Information by Source (Leaves, Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, Other Sources), Type (Phenylpropanoids, Alkaloids, Terpenoids, Polyketides), Application (Pharmaceuticals, Cosmetics, Food & Beverages, Dietary Supplements, Others, Forecast Till 2032
In 2023, the High Value Plant Compound Market Size was estimated to be USD 16,536.70 million. The Global High Value Plant Compound industry is anticipated to experience a compound annual growth rate (CAGR) of 11.69% from 2024 to 2032, resulting in a total value of USD 44,724.70 million.
The demand for plant-based supplements and nutraceuticals is being driven by the global health and wellness trend. Dietary supplements that promote overall health and address health issues are prepared using high-quality plant compounds. The demand for natural and organic products in a variety of industries, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages, is the primary driver of the global high-value plant compounds market. The market has experienced growth as a result of the increasing consumer awareness of the health benefits of these compounds and the increasing preference for natural products over synthetic ones. Nevertheless, the market is confronted with a variety of obstacles, including the high cost of extraction processes, regulatory obstacles, and concerns regarding the sustainable procurement of plant materials. It is anticipated that market participants will experience lucrative opportunities as a result of technological advancements in extraction techniques and a focus on research and development activities.
Market segment insights
Table 1 illustrates a substantial upward trajectory in the global market for high-value plant compounds from 2022 to 2032. The market, which was valued at USD 14,919.4 million in 2022, is expected to experience a Compound Annual Growth Rate (CAGR) of 11.7% from 2023 to 2032, culminating in a spectacular USD 44,724.7 million in 2032. These compounds, which are derived from a variety of plant sources, are of significant value because they are used in industries such as pharmaceuticals, cosmetics, and food.
Leaves comprise the greatest portion of this market among the various plant sources. Leaves generated USD 4,730.6 million in 2022, and this sector is anticipated to expand at a compound annual growth rate (CAGR) of 11.8%. The substantial increase in the leaves category can be attributed to the growing demand for herbal and botanical constituents in healthcare and wellness products. Rhizomes & Roots, Barks & Stems, Fruits, Flowers, & Bulbs, and Other Sources are also significant contributors to this market, with CAGRs of 12.2%, 10.7%, 12.0%, and 11.5%, respectively.
One of the fastest-growing segments in the market is phenylpropanoids, including curcumin and resveratrol, with a compound annual growth rate (CAGR) of 11.7%. The antioxidant and anti-inflammatory properties of these compounds have made them a popular ingredient in dietary supplements and cosmetic products. Alkaloids and terpenoids are also positioned for significant growth, with anticipated compound annual growth rates (CAGRs) of 11.8% and 11.6%, respectively.
Regional Perspectives
In 2022, North America was the greatest market, with a market valuation of $4.3 billion. between 2022 and 2032, the region experienced substantial growth, with a Compound Annual Growth Rate (CAGR) of 11.21%. The burgeoning interest in natural remedies, dietary supplements, and wellness products is the primary factor driving the expansion of the high-value plant compounds market in North America.
Europe, which had a market value of $3.4 billion in 2022, exhibited a compound annual growth rate (CAGR) of 10.74% during the same period, indicating consistent growth. The market has expanded because of the adoption of high-value plant compounds by European consumers, particularly in cosmetics and dietary supplements.
The market value of $6.7 billion in 2022 was achieved by the Asia-Pacific region, which exhibited the maximum CAGR at 12.02% during the same period. The region's robust CAGR can be attributed to the extensive adoption of herbal and Ayurvedic remedies in the pharmaceutical and food industries, as well as the increasing popularity of these remedies in countries such as India and China.
Merck KGaA, MedChemExpress, Selleck Chemicals, Biosynth, Tokyo Chemical Industry, Advion, Inc, Alkaloids Corporation, C-Squared Pharma S.a R.L., Linnea SA, and Inga Pharmaceuticals are among the key companies in the High Value Plant Compound market.